What? The last two ABS offerings in this quarter were not a big enough cash infusion for you? I thought you said net cash flow was not your issue.
Two? I thought only one $185mln MyPower deal. The other one for $57.45mln is still in works (underlying cashflows represent $76.4mln but the ABS is for 57.45). In Q4 there were no ABS deals but still non-recourse went up. So my understanding is that assets simply move from one non-recourse facility to another. So in a nutshell how much this will help avoid new recourse debt is anyone's guess. Overall even if a new cash infusion comes in say around 200mln, that will buy just another quarter. Unless the business model changes, this is a game of surviving one quarter at a time. One misstep - game over. More importantly I think Q2 guidance will come in quite soft at ~200MWs and they might simply abandon the yearly guidance. That will plummet the stock, as market seems to understand guidance more than the underlying cashflow dynamic.
Also, we have to see how the $57.45mln ABS pricing comes out. I am not optimistic on that one. Bad pricing on that deal will blow another hole into the long thesis, if not a death knell.